Pfeilstocker et al evaluated the role of cytogenetics in determining the prognosis for patients with myelodysplasia. They developed the Prognostic Index for Cytogenetics (pi score) for risk stratification based on bone marrow cytogenetic findings. The authors are from Boltzmann Institute for Leukemia Research and Haematology at the Hanusch Hospital in Vienna, Austria.